Dissolving Microneedle Patch for Peripheral Delivery of Pregabalin in Neuropathic Pain Management
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202500316 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Aining Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, P. R. China. Hauptthemen laut MEDLINE: Pregabalin, Neuralgia, Needles, Drug Delivery Systems. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Outstanding Talented Young Doctor Program of Hubei Province, Translational Medicine and Interdisciplinary Research Joint Fund of Zhongnan Hospital of Wuhan University.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Neuropathic pain is a complex and debilitating condition that presents substantial challenges for effective treatment, as it often persists despite conventional therapies and can significantly impair the quality of life of affected individuals. Currently, pregabalin is the first‐line treatment for neuropathic pain. However, its oral dosage form is often associated with adverse reactions such as dizziness and drowsiness, and its administration duration is limited, requiring frequent dosing. To address these issues, this study developed a hyaluronic acid (HA)‐based dissolving microneedle (MN) patch incorporating poly (lactic‐co‐glycolic acid) (PLGA) microspheres (MS) loaded with pregabalin (PG) for peripheral administration. The MN array consists of 10 × 10 needles, covering an area of ≈0.5 cm 2 , with each needle having a height of 850 µm. The MN patch demonstrated significant analgesic effects and sustained drug release at the application site for up to 48 h, effectively alleviating pain while minimizing dizziness and drowsiness, which are the most common side effects after systemic administration. This innovative MN platform presents a promising strategy for neuropathic pain management and provides a novel therapeutic paradigm for the peripheral application of centrally acting analgesics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Zhongnan Hospital of Wuhan University, Wuhan, 430071, P. R. China.
- Department of Burns, Tongren Hospital of Wuhan University (Wuhan Third Hospital), School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, P. R. China.
- TaiKang Center for Life and Medical Sciences, Wuhan University, Wuhan, 430071, P. R. China.
- Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan, 430071, P. R. China.
ORCID-Profile: Aining Zhang, Mian Peng
Förderung
- National Natural Science Foundation of China
- Outstanding Talented Young Doctor Program of Hubei Province
- Translational Medicine and Interdisciplinary Research Joint Fund of Zhongnan Hospital of Wuhan University
Zitieren
APA
Zhang, A., Wu, W., Wang, S., Liu, X., Jiang, X., Xiao, Y., Li, W., & Peng, M. (2025). Dissolving Microneedle Patch for Peripheral Delivery of Pregabalin in Neuropathic Pain Management. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202500316
Vancouver
Zhang A, Wu W, Wang S, Liu X, Jiang X, Xiao Y, et al. Dissolving Microneedle Patch for Peripheral Delivery of Pregabalin in Neuropathic Pain Management. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202500316
BibTeX
@article{Zhang2025,
author = {Zhang, Aining and Wu, Wenxin and Wang, Siyuan and Liu, Xin and Jiang, Xue and Xiao, Yangwenzheng and Li, Wei and Peng, Mian},
title = {Dissolving Microneedle Patch for Peripheral Delivery of Pregabalin in Neuropathic Pain Management},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202500316}
}
EUVIMED